Takeda
TAK-755
Thrombotic Thrombocytopenic Purpura (TTP)
Countdown
252days
Phase 3 readout · Mar 16, 2027
What's at stake
Phase 3 trial results for TAK-755 in Thrombotic Thrombocytopenic Purpura (TTP) are due Mar 16, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 14h ago
“CT.gov NCT04683003: Phase 3 trial, sponsor Takeda, drug TAK-755. Primary completion date 2027-03-16 (estimated).”